79 related articles for article (PubMed ID: 38622479)
21. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.
Stone JH; Frigault MJ; Serling-Boyd NJ; Fernandes AD; Harvey L; Foulkes AS; Horick NK; Healy BC; Shah R; Bensaci AM; Woolley AE; Nikiforow S; Lin N; Sagar M; Schrager H; Huckins DS; Axelrod M; Pincus MD; Fleisher J; Sacks CA; Dougan M; North CM; Halvorsen YD; Thurber TK; Dagher Z; Scherer A; Wallwork RS; Kim AY; Schoenfeld S; Sen P; Neilan TG; Perugino CA; Unizony SH; Collier DS; Matza MA; Yinh JM; Bowman KA; Meyerowitz E; Zafar A; Drobni ZD; Bolster MB; Kohler M; D'Silva KM; Dau J; Lockwood MM; Cubbison C; Weber BN; Mansour MK;
N Engl J Med; 2020 Dec; 383(24):2333-2344. PubMed ID: 33085857
[TBL] [Abstract][Full Text] [Related]
22. Anti-IL-6 Receptor Tocilizumab in Refractory Graves' Orbitopathy: National Multicenter Observational Study of 48 Patients.
Sánchez-Bilbao L; Martínez-López D; Revenga M; López-Vázquez Á; Valls-Pascual E; Atienza-Mateo B; Valls-Espinosa B; Maiz-Alonso O; Blanco A; Torre-Salaberri I; Rodríguez-Méndez V; García-Aparicio Á; Veroz-González R; Jovaní V; Peiteado D; Sánchez-Orgaz M; Tomero E; Toyos-Sáenz de Miera FJ; Pinillos V; Aurrecoechea E; Mora Á; Conesa A; Fernández-Prada M; Troyano JA; Calvo-Río V; Demetrio-Pablo R; González-Mazón Í; Hernández JL; Castañeda S; González-Gay MÁ; Blanco R
J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32878150
[TBL] [Abstract][Full Text] [Related]
23. Prospective Correlation of Risk of Obstructive Sleep Apnea With Severe Clinical Features of Thyroid Eye Disease.
Godfrey KJ; Schmuter G; Hu B; Tooley AA; Dunbar KE; Basner RC; Kazim M
Ophthalmic Plast Reconstr Surg; 2021 May-Jun 01; 37(3S):S58-S61. PubMed ID: 32852372
[TBL] [Abstract][Full Text] [Related]
24. Tocilizumab in patients with severe COVID-19: a retrospective cohort study.
Guaraldi G; Meschiari M; Cozzi-Lepri A; Milic J; Tonelli R; Menozzi M; Franceschini E; Cuomo G; Orlando G; Borghi V; Santoro A; Di Gaetano M; Puzzolante C; Carli F; Bedini A; Corradi L; Fantini R; Castaniere I; Tabbì L; Girardis M; Tedeschi S; Giannella M; Bartoletti M; Pascale R; Dolci G; Brugioni L; Pietrangelo A; Cossarizza A; Pea F; Clini E; Salvarani C; Massari M; Viale PL; Mussini C
Lancet Rheumatol; 2020 Aug; 2(8):e474-e484. PubMed ID: 32835257
[TBL] [Abstract][Full Text] [Related]
25. Tocilizumab in glucocorticoid-resistant graves orbitopathy. A case series report of a mexican population.
Ceballos-Macías José J; Rivera-Moscoso R; Flores-Real Jorge A; Vargas-Sánchez J; Ortega-Gutiérrez G; Madriz-Prado R; Velasco-Ramos PC; Muñoz-Monroy Omar E; Meneses-Pérez Anna C; Fernández-Morales Irma N; Hernández-Moreno A
Ann Endocrinol (Paris); 2020 Jun; 81(2-3):78-82. PubMed ID: 32340849
[TBL] [Abstract][Full Text] [Related]
26. Thyroid-associated ophthalmopathy: Emergence of teprotumumab as a promising medical therapy.
Smith TJ
Best Pract Res Clin Endocrinol Metab; 2020 Jan; 34(1):101383. PubMed ID: 32088116
[TBL] [Abstract][Full Text] [Related]
27. Teprotumumab for the Treatment of Active Thyroid Eye Disease.
Douglas RS; Kahaly GJ; Patel A; Sile S; Thompson EHZ; Perdok R; Fleming JC; Fowler BT; Marcocci C; Marinò M; Antonelli A; Dailey R; Harris GJ; Eckstein A; Schiffman J; Tang R; Nelson C; Salvi M; Wester S; Sherman JW; Vescio T; Holt RJ; Smith TJ
N Engl J Med; 2020 Jan; 382(4):341-352. PubMed ID: 31971679
[TBL] [Abstract][Full Text] [Related]
28. Immunotherapies for thyroid eye disease.
Kahaly GJ
Curr Opin Endocrinol Diabetes Obes; 2019 Oct; 26(5):250-255. PubMed ID: 31356255
[TBL] [Abstract][Full Text] [Related]
29. Subcutaneous Tocilizumab for Thyroid Eye Disease: Simplified Dosing and Delivery.
Copperman T; Idowu OO; Kersten RC; Vagefi MR
Ophthalmic Plast Reconstr Surg; 2019; 35(3):e64-e66. PubMed ID: 30865069
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors of prognosis after radiation and steroid pulse therapy in thyroid eye disease.
Ito M; Takahashi Y; Katsuda E; Oshima Y; Takeuchi A; Mori T; Abe S; Mori Y; Kakizaki H; Suzuki K
Sci Rep; 2019 Feb; 9(1):2027. PubMed ID: 30765815
[TBL] [Abstract][Full Text] [Related]
31. Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection.
Biggioggero M; Crotti C; Becciolini A; Favalli EG
Drug Des Devel Ther; 2019; 13():57-70. PubMed ID: 30587928
[TBL] [Abstract][Full Text] [Related]
32. Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidism.
Wiersinga W; Žarković M; Bartalena L; Donati S; Perros P; Okosieme O; Morris D; Fichter N; Lareida J; von Arx G; Daumerie C; Burlacu MC; Kahaly G; Pitz S; Beleslin B; Ćirić J; Ayvaz G; Konuk O; Törüner FB; Salvi M; Covelli D; Curro N; Hegedüs L; Brix T;
Eur J Endocrinol; 2018 Jun; 178(6):635-643. PubMed ID: 29650691
[TBL] [Abstract][Full Text] [Related]
33. Tocilizumab: A Review in Rheumatoid Arthritis.
Scott LJ
Drugs; 2017 Nov; 77(17):1865-1879. PubMed ID: 29094311
[TBL] [Abstract][Full Text] [Related]
34. Tocilizumab (Actemra).
Sheppard M; Laskou F; Stapleton PP; Hadavi S; Dasgupta B
Hum Vaccin Immunother; 2017 Sep; 13(9):1972-1988. PubMed ID: 28841363
[TBL] [Abstract][Full Text] [Related]
35. Advances in the management of thyroid eye diseases: An overview.
Kumari R; Chandra Saha B
Int Ophthalmol; 2018 Oct; 38(5):2247-2255. PubMed ID: 28822031
[TBL] [Abstract][Full Text] [Related]
36. Treatment of Rheumatoid Arthritis With Anti-Tumor Necrosis Factor or Tocilizumab Therapy as First Biologic Agent in a Global Comparative Observational Study.
Choy EH; Bernasconi C; Aassi M; Molina JF; Epis OM
Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1484-1494. PubMed ID: 28622454
[TBL] [Abstract][Full Text] [Related]
37. Teprotumumab for Thyroid-Associated Ophthalmopathy.
Smith TJ; Kahaly GJ; Ezra DG; Fleming JC; Dailey RA; Tang RA; Harris GJ; Antonelli A; Salvi M; Goldberg RA; Gigantelli JW; Couch SM; Shriver EM; Hayek BR; Hink EM; Woodward RM; Gabriel K; Magni G; Douglas RS
N Engl J Med; 2017 May; 376(18):1748-1761. PubMed ID: 28467880
[TBL] [Abstract][Full Text] [Related]
38. Clinical Response to Tocilizumab in Severe Thyroid Eye Disease.
Sy A; Eliasieh K; Silkiss RZ
Ophthalmic Plast Reconstr Surg; 2017; 33(3):e55-e57. PubMed ID: 27281483
[TBL] [Abstract][Full Text] [Related]
39. Pathogenesis of thyroid eye disease: review and update on molecular mechanisms.
Khong JJ; McNab AA; Ebeling PR; Craig JE; Selva D
Br J Ophthalmol; 2016 Jan; 100(1):142-50. PubMed ID: 26567024
[TBL] [Abstract][Full Text] [Related]
40. Smoking was associated with poor response to intravenous steroids therapy in Graves' ophthalmopathy.
Xing L; Ye L; Zhu W; Shen L; Huang F; Jiao Q; Zhou X; Wang S; Wang W; Ning G
Br J Ophthalmol; 2015 Dec; 99(12):1686-91. PubMed ID: 26061160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
